Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Oxford Vacmedix Raises $12.5 Million for Therapeutic Vaccines from Asian Investors

publication date: Mar 7, 2018

Oxford Vacmedix, a UK-Changzhou biopharma, closed a $12.5 million Series A funding from South Korean and China investors to develop therapeutic cancer vaccines. OVM's two lead vaccines target cervical cancer and solid tumors, respectively, by stimulating CD4 and CD8 responses. The company expects the money will be enough to complete pre-clinical development of the vaccines and begin Phase I trials. Investors in the funding were Cancer ROP, a South Korea diagnostics company, and existing shareholders in China, who also supported the company's Changzhou facility. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here